國立虎尾科技大學 |

Small molecules for cancer treatment

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Small molecules for cancer treatment/ edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy.
other author:	Pathak, Surajit.
Published:	Singapore :Springer Nature Singapore : : 2024.,
Description:	xiii, 269 p. :ill. (chiefly color), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
Subject:	Cancer - Treatment. -
Online resource:	https://doi.org/10.1007/978-981-96-0301-5
ISBN:	9789819603015

Small molecules for cancer treatment
Small molecules for cancer treatment[electronic resource] /edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy. - Singapore :Springer Nature Singapore :2024. - xiii, 269 p. :ill. (chiefly color), digital ;24 cm.

1. Small Molecule Therapeutics targeting Ligand-independent activation of Androgen Receptor in Prostate Cancer -- 2. Small molecule targeted compounds for cancer therapy through different pathways -- 3. Exploring small molecule therapies: A comprehensive study on their efficacy in cancer treatment -- 4. Unvailing The Symphony Of Small Molecules In Cutaneous Harmony, Pathophysiology And Regeneration -- 5. Relevance Of Small Molecule Inhibitors in Advancing Cancer Therapeutics -- 6. Application of artificial intelligence in small molecules in cancer therapy -- 7. Role Of Peptides In Oral Cancer -- 8. Innovative Strategies in Cancer Therapy: Overcoming Challenges through Small Molecule and Peptide Design -- 9. Therapeutic Relevance Of Glycosylation Inhibitors In Cancer -- 10. Developments of aptamer-drug conjugates for targeted cancer therapy -- 11. Natural small molecules and their anti-cancer effects -- 12. Small Molecule Inhibitors: Precision Tools Targeting Oncogenic Pathways for Therapeutic Intervention in Cancer -- 13. Small Molecules And Peptides Targetting Tumour Microenvironment.

The book explores role of small molecules and peptides in cancer therapy, with a focus on (Aptamer-drug conjugates, Androgen Receptor and Tyrosine Kinase inhibitors, and Glycosylation inhibitors. Small molecule inhibitors targeting oncogenic pathways such as EGFR and PI3K inhibitors, Peptides in oral cancer such as Antimicrobial peptides, Cell Penetrating Peptides, Tumour targeting peptides, Natural small molecules with anti-cancer effects such as phenolic compounds, alkaloids, terpenoids and steroids, Phthalides and lectins, Peptides targeting the tumor microenvironment such as GM-CSF's, LAG3, PD 1, CCL2, CCR-5, CXCR4 inhibitors). An introductory chapter covers the foundation for understanding their significance in cancer treatment. The book delves into the versatility and precision of small molecules, highlighting their advantages in drug delivery and formulation strategies. It emphasizes the expansion of therapeutic horizons through small molecule peptides, shedding light on their potential in targeting tumor microenvironments and advancing cancer therapeutics. Additionally, the book discusses combination therapies and synergistic effects, offering a deeper understanding of integrating different therapeutic approaches. Furthermore, it addresses emerging trends, challenges, safety considerations, and the relevance of small-molecule inhibitors. This book provides a crucial update on the latest advancements and serves as a valuable resource for researchers, clinicians, and students interested in the rapidly evolving landscape of cancer treatment, offering an overview of the potential and complexities associated with these compounds in the fight against cancer.

ISBN: 9789819603015

Standard No.: 10.1007/978-981-96-0301-5doiSubjects--Topical Terms:

661325
Cancer
--Treatment.

LC Class. No.: RC270.8

Dewey Class. No.: 616.99406

Small molecules for cancer treatment
LDR:03793nam a2200325 a 4500 001 1153174
003 DE-He213
005 20250130115230.0
006 m o d
007 cr nn 008maaau
008 250618s2024 si s 0 eng d
020 $a 9789819603015 $q (electronic bk.)
020 $a 9789819603008 $q (paper)
024 7 $a 10.1007/978-981-96-0301-5 $2 doi
035 $a 978-981-96-0301-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8
072 7 $a PSA $2 bicssc
072 7 $a SCI086000 $2 bisacsh
072 7 $a PSA $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .S635 2024
245 0 0 $a Small molecules for cancer treatment $h [electronic resource] / $c edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy.
260 $a Singapore : $c 2024. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a xiii, 269 p. : $b ill. (chiefly color), digital ; $c 24 cm.
505 0 $a 1. Small Molecule Therapeutics targeting Ligand-independent activation of Androgen Receptor in Prostate Cancer -- 2. Small molecule targeted compounds for cancer therapy through different pathways -- 3. Exploring small molecule therapies: A comprehensive study on their efficacy in cancer treatment -- 4. Unvailing The Symphony Of Small Molecules In Cutaneous Harmony, Pathophysiology And Regeneration -- 5. Relevance Of Small Molecule Inhibitors in Advancing Cancer Therapeutics -- 6. Application of artificial intelligence in small molecules in cancer therapy -- 7. Role Of Peptides In Oral Cancer -- 8. Innovative Strategies in Cancer Therapy: Overcoming Challenges through Small Molecule and Peptide Design -- 9. Therapeutic Relevance Of Glycosylation Inhibitors In Cancer -- 10. Developments of aptamer-drug conjugates for targeted cancer therapy -- 11. Natural small molecules and their anti-cancer effects -- 12. Small Molecule Inhibitors: Precision Tools Targeting Oncogenic Pathways for Therapeutic Intervention in Cancer -- 13. Small Molecules And Peptides Targetting Tumour Microenvironment.
520 $a The book explores role of small molecules and peptides in cancer therapy, with a focus on (Aptamer-drug conjugates, Androgen Receptor and Tyrosine Kinase inhibitors, and Glycosylation inhibitors. Small molecule inhibitors targeting oncogenic pathways such as EGFR and PI3K inhibitors, Peptides in oral cancer such as Antimicrobial peptides, Cell Penetrating Peptides, Tumour targeting peptides, Natural small molecules with anti-cancer effects such as phenolic compounds, alkaloids, terpenoids and steroids, Phthalides and lectins, Peptides targeting the tumor microenvironment such as GM-CSF's, LAG3, PD 1, CCL2, CCR-5, CXCR4 inhibitors). An introductory chapter covers the foundation for understanding their significance in cancer treatment. The book delves into the versatility and precision of small molecules, highlighting their advantages in drug delivery and formulation strategies. It emphasizes the expansion of therapeutic horizons through small molecule peptides, shedding light on their potential in targeting tumor microenvironments and advancing cancer therapeutics. Additionally, the book discusses combination therapies and synergistic effects, offering a deeper understanding of integrating different therapeutic approaches. Furthermore, it addresses emerging trends, challenges, safety considerations, and the relevance of small-molecule inhibitors. This book provides a crucial update on the latest advancements and serves as a valuable resource for researchers, clinicians, and students interested in the rapidly evolving landscape of cancer treatment, offering an overview of the potential and complexities associated with these compounds in the fight against cancer.
650 0 $a Cancer $x Treatment. $3 661325
650 0 $a Cancer $x Molecular aspects. $3 668357
650 0 $a Biology. $3 599573
650 0 $a Cancer. $3 581034
650 0 $a Oncology. $3 593951
650 1 4 $a Biological Sciences. $3 790542
650 2 4 $a Cancer Biology. $3 1388882
650 2 4 $a Cancer Therapy. $3 1389305
700 1 $a Pathak, Surajit. $e editor. $3 1327551
700 1 $a Banerjee, Antara. $e editor. $3 1327552
700 1 $a Duttaroy, Asim K. $3 1111136
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-96-0301-5
950 $a Medicine (SpringerNature-11650)